Evidence map›Paper›PMID 25259918›Full record

ArticleCell2014

Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression.

Leandro Z Agudelo, Teresa Femenía, Funda Orhan, Margareta Porsmyr-Palmertz, Michel Goiny, Vicente Martinez-Redondo, Jorge C Correia, Manizheh Izadi, Maria Bhat, Ina Schuppe-Koistinen and 8 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 405 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
405citing papers in PubMed, 12 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

405 citing papers in PubMed, 12 syntheses or guidelines pooled it, 711 citations in OpenAlex.

  1. A Single Exercise Session Elicits a Transient Kynurenine Metabolic Signature in Health and Disease: A Systematic Review and Meta-Analysis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Yoga for fatigue in people with cancer.The Cochrane database of systematic reviews · 2025
    Pooled it
  7. Cardiovascular training for fatigue in people with cancer.The Cochrane database of systematic reviews · 2025
    Pooled it
  8. Pooled it
  9. Resistance training for fatigue in people with cancer.The Cochrane database of systematic reviews · 2024
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

345 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Leandro Z AgudeloDepartment of Physiology and Pharmacology, Molecular and Cellular Exercise Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Teresa FemeníaDepartment of Physiology and Pharmacology, Molecular and Cellular Exercise Physiology, Karolinska Institutet, 17177 Stockholm, Sweden; Department of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.
Funda OrhanDepartment of Physiology and Pharmacology, Neuropsychoimmunology, Karolinska Institutet, 17177 Stockholm, Sweden.
Margareta Porsmyr-PalmertzDepartment of Physiology and Pharmacology, Molecular and Cellular Exercise Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Michel GoinyDepartment of Physiology and Pharmacology, Neuropsychoimmunology, Karolinska Institutet, 17177 Stockholm, Sweden.
Vicente Martinez-RedondoDepartment of Physiology and Pharmacology, Molecular and Cellular Exercise Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Jorge C CorreiaDepartment of Physiology and Pharmacology, Molecular and Cellular Exercise Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Manizheh IzadiDepartment of Physiology and Pharmacology, Molecular and Cellular Exercise Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Maria BhatAstraZeneca R&D, Innovative Medicines, Personalized Healthcare and Biomarkers, Translational Science Center, Science for Life Laboratory, 17165 Solna, Sweden; Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.
Ina Schuppe-KoistinenAstraZeneca R&D, Innovative Medicines, Personalized Healthcare and Biomarkers, Translational Science Center, Science for Life Laboratory, 17165 Solna, Sweden; Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.
Amanda T PetterssonDepartment of Physiology and Pharmacology, Molecular and Cellular Exercise Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Duarte M S FerreiraDepartment of Physiology and Pharmacology, Molecular and Cellular Exercise Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Anna KrookDepartment of Physiology and Pharmacology, Integrative Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Romain BarresDepartment of Physiology and Pharmacology, Integrative Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Juleen R ZierathDepartment of Physiology and Pharmacology, Integrative Physiology, Karolinska Institutet, 17177 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Integrative Physiology, Karolinska Institutet, 17177 Stockholm, Sweden.
Sophie ErhardtDepartment of Physiology and Pharmacology, Neuropsychoimmunology, Karolinska Institutet, 17177 Stockholm, Sweden.
Maria LindskogDepartment of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden. Electronic address: mia.lindskog@ki.se.
Jorge L RuasDepartment of Physiology and Pharmacology, Molecular and Cellular Exercise Physiology, Karolinska Institutet, 17177 Stockholm, Sweden. Electronic address: jorge.ruas@ki.se.
Karolinska Institutet · SEScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is a debilitating condition with a profound impact on quality of life for millions of people worldwide. Physical exercise is used as a treatment strategy for many patients, but the mechanisms that underlie its beneficial effects remain unknown. Here, we describe a mechanism by which skeletal muscle PGC-1α1 induced by exercise training changes kynurenine metabolism and protects from stress-induced depression. Activation of the PGC-1α1-PPARα/δ pathway increases skeletal muscle expression of kynurenine aminotransferases, thus enhancing the conversion of kynurenine into kynurenic acid, a metabolite unable to cross the blood-brain barrier. Reducing plasma kynurenine protects the brain from stress-induced changes associated with depression and renders skeletal muscle-specific PGC-1α1 transgenic mice resistant to depression induced by chronic mild stress or direct kynurenine administration. This study opens therapeutic avenues for the treatment of depression by targeting the PGC-1α1-PPAR axis in skeletal muscle, without the need to cross the blood-brain barrier.

Indexed as

AnimalsBlood-Brain BarrierDepressionGene Expression ProfilingHumansKynurenic AcidKynurenineMiceMuscle Fibers, SkeletalMuscle, SkeletalPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhysical Conditioning, AnimalPhysical Conditioning, HumanPPAR alphaStress, PsychologicalTransaminasesKynurenic AcidKynureninekynurenine-oxoglutarate transaminasePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPAR alphaPPARGC1A protein, humanPpargc1a protein, mouseTransaminasesTranscription Factors

Identifiers

PMID25259918
OpenAlexW2117415152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.